In order to explore the clinical importance of our results, we collected archived data of HER2-positive breast cancer in our hospital as the validation cohort (n=40, Tab 1) and online data from the TCGA-BRCA database (n=1,222, Tab 2). Here, ERBB2 is linked to breast carcinoma.